BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10358173)

  • 1. IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells.
    Galon J; Sudarshan C; Ito S; Finbloom D; O'Shea JJ
    J Immunol; 1999 Jun; 162(12):7256-62. PubMed ID: 10358173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12.
    Matikainen S; Paananen A; Miettinen M; Kurimoto M; Timonen T; Julkunen I; Sareneva T
    Eur J Immunol; 2001 Jul; 31(7):2236-45. PubMed ID: 11449378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages.
    Lehtonen A; Matikainen S; Julkunen I
    J Immunol; 1997 Jul; 159(2):794-803. PubMed ID: 9218597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells.
    Wang KS; Ritz J; Frank DA
    J Immunol; 1999 Jan; 162(1):299-304. PubMed ID: 9886399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.
    Strengell M; Julkunen I; Matikainen S
    J Leukoc Biol; 2004 Aug; 76(2):416-22. PubMed ID: 15178704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs.
    Rogge L; D'Ambrosio D; Biffi M; Penna G; Minetti LJ; Presky DH; Adorini L; Sinigaglia F
    J Immunol; 1998 Dec; 161(12):6567-74. PubMed ID: 9862683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.
    Goenka S; Youn J; Dzurek LM; Schindler U; Yu-Lee LY; Boothby M
    J Immunol; 1999 Nov; 163(9):4663-72. PubMed ID: 10528163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation.
    Cho SS; Bacon CM; Sudarshan C; Rees RC; Finbloom D; Pine R; O'Shea JJ
    J Immunol; 1996 Dec; 157(11):4781-9. PubMed ID: 8943379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
    Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
    Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice.
    Kaplan MH; Sun YL; Hoey T; Grusby MJ
    Nature; 1996 Jul; 382(6587):174-7. PubMed ID: 8700209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.
    Thierfelder WE; van Deursen JM; Yamamoto K; Tripp RA; Sarawar SR; Carson RT; Sangster MY; Vignali DA; Doherty PC; Grosveld GC; Ihle JN
    Nature; 1996 Jul; 382(6587):171-4. PubMed ID: 8700208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
    Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
    Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontline: absence of functional STAT4 activation despite detectable tyrosine phosphorylation induced by murine IFN-alpha.
    Berenson LS; Farrar JD; Murphy TL; Murphy KM
    Eur J Immunol; 2004 Sep; 34(9):2365-74. PubMed ID: 15307169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet light suppresses IFN-gamma-induced IL-7 gene expression in murine keratinocytes by interfering with IFN regulatory factors.
    Aragane Y; Schwarz A; Luger TA; Ariizumi K; Takashima A; Schwarz T
    J Immunol; 1997 Jun; 158(11):5393-9. PubMed ID: 9164960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.
    Afkarian M; Sedy JR; Yang J; Jacobson NG; Cereb N; Yang SY; Murphy TL; Murphy KM
    Nat Immunol; 2002 Jun; 3(6):549-57. PubMed ID: 12006974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice.
    Salkowski CA; Kopydlowski K; Blanco J; Cody MJ; McNally R; Vogel SN
    J Immunol; 1999 Aug; 163(3):1529-36. PubMed ID: 10415056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontline: interferon regulatory factor-1 as a protective gene in intestinal inflammation: role of TCR gamma delta T cells and interleukin-18-binding protein.
    Siegmund B; Sennello JA; Lehr HA; Senaldi G; Dinarello CA; Fantuzzi G
    Eur J Immunol; 2004 Sep; 34(9):2356-64. PubMed ID: 15307168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-alpha and IL-12 activate IFN regulatory factor 1 (IRF-1), IRF-4, and IRF-8 gene expression in human NK and T cells.
    Lehtonen A; Lund R; Lahesmaa R; Julkunen I; Sareneva T; Matikainen S
    Cytokine; 2003 Nov; 24(3):81-90. PubMed ID: 14581002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.